Diversity and inclusion are of paramount importance in promoting creative thinking for organizations and startups. And certainly an industry that thrives on being innovative and disruptive has every reason to be a frontrunner in bridging the gap and amplifying...
Small and start-up medtech companies are often so focused on technology development and the immediate demands of the job at hand that they have little bandwidth for issues that seem less urgent — like building a diverse team. According to the Diversity in MedTech...
Fogarty Innovation is always honored to have a seat at the table at significant industry events, and the most recent was MedTech Strategist’s Innovation Summit San Francisco 2021, where we were an organizing partner along with Deerfield Partners, Lightstone Ventures,...
Do you speak fluent CPT®? If not, as a health technology entrepreneur, you likely need to learn more about how a new medical device or procedure fits into the Current Procedural Terminology (CPT) code landscape. That was the topic of a recent American Medical...
Kidney stones, hard deposits of minerals and salts that form inside the kidneys, are among the most painful conditions, sending more than half a million people to the emergency room each year. An estimated one in 10 people will suffer from kidney stones at some point...
Encouraging the next generation of healthtech problem solvers is a key goal of Fogarty Innovation, and this summer it partnered with Stanford University’s inaugural two-week Surgical Technology & Entrepreneurship program for high school students to expose young...
Approximately 100,000 U.S. patients require a kidney transplant each year, with some waiting more than five years for a donor, and up to half of those dying in the interim. And even for the “lucky” ones who receive a transplant, there are still hurdles. In fact, one...
Ingrid Ellerbe has joined Diversity by Doing Healthtech (DxD), the health technology industry diversity initiative led by the Stanford Byers Center for Biodesign and Fogarty Innovation, as executive director. Ellerbe, who has spent the last 30 years helping...
The Medical Device Manufacturers Association (MDMA) has been a beacon during the COVID-19 crisis, working closely with the FDA and other key stakeholders to represent the needs of its members and bring innovative devices to patients swiftly but safely. That’s why...
At the most recent Stanford Biodesign’s “From the Innovator's Workbench” lecture series, the second of its 20th anniversary year, three high-powered women health tech leaders opened up about pivotal moments in their recent successes in bringing...